Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chlamydia Trachomatis
Azithromycin treatment significantly reduces pelvic inflammation
August 11th, 2005
Azithromycin treatment significantly reduces pelvic inflammation due to chlamydia. According to scientists from the United States, "We inoculated 45 female macaques in the cervix with Chlamydia trachomatis once weekly for 5 weeks and randomly assigned them to treatment with doxycycline (n=12), azithromycin (n=12), or placebo (n=21). At hysterectomy, cervical cultures remained positive in 12 of 21 placebo-treated monkeys, versus 0 of 12 21 doxycycline- or azithromycin-treated monkeys (p<.01); cervical ligase chain reaction remained positive in 15 placebo-, 1 doxycycline-, and 0 azithromycin-treated monkeys." "Tubal swabs remained positive in...
Source: Women's Health Weekly (2005-08-11)
|
